PhysIOL SA and Carl Zeiss Meditec AG have settled their legal dispute about patents and utility models for trifocal intraocular lenses (IOL) out of court.
Under a Settlement agreement, the two parties have agreed to permit the unrestricted distribution of products from the FINEVISION line (PhysIOL SA) and AT LISA tri line (Carl Zeiss Meditec AG) as well as products based on this technology. Contrary to a statement made in an earlier press release by PhysIOL SA in the course of the proceedings, PhysIOL SA recognized IP rights held by Carl Zeiss Meditec AG and therefore accepted entering into an agreement with...